ClinicalTrials.govpublic full text
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
central nervous system tumor, pediatric, glioma, ependymoma, medulloblastoma, germ cell tumor, atypical teratoid/rhabdoid tumor, primitive neuroectodermal tumor, choroid plexus carcinoma, pineoblastoma, cns, car t cell, her2-positive, brain tumor, pediatric, young adults, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 840679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.